Characteristics of COVID-19 infection in Beijing
- PMID: 32112886
- PMCID: PMC7102527
- DOI: 10.1016/j.jinf.2020.02.018
Characteristics of COVID-19 infection in Beijing
Abstract
Background: Since the first case of a novel coronavirus (COVID-19) infection pneumonia was detected in Wuhan, China, a series of confirmed cases of the COVID-19 were found in Beijing. We analyzed the data of 262 confirmed cases to determine the clinical and epidemiological characteristics of COVID-19 in Beijing.
Methods: We collected patients who were transferred by Beijing Emergency Medical Service to the designated hospitals. The information on demographic, epidemiological, clinical, laboratory test for the COVID-19 virus, diagnostic classification, cluster case and outcome were obtained. Furthermore we compared the characteristics between severe and common confirmed cases which including mild cases, no-pneumonia cases and asymptomatic cases, and we also compared the features between COVID-19 and 2003 SARS.
Findings: By Feb 10, 2020, 262 patients were transferred from the hospitals across Beijing to the designated hospitals for special treatment of the COVID-19 infected by Beijing emergency medical service. Among of 262 patients, 46 (17.6%) were severe cases, 216 (82.4%) were common cases, which including 192 (73.3%) mild cases, 11(4.2%) non-pneumonia cases and 13 (5.0%) asymptomatic cases respectively. The median age of patients was 47.5 years old and 48.5% were male. 192 (73.3%) patients were residents of Beijing, 50 (26.0%) of which had been to Wuhan, 116 (60.4%) had close contact with confirmed cases, 21 (10.9%) had no contact history. The most common symptoms at the onset of illness were fever (82.1%), cough (45.8%), fatigue (26.3%), dyspnea (6.9%) and headache (6.5%). The median incubation period was 6.7 days, the interval time from between illness onset and seeing a doctor was 4.5 days. As of Feb 10, 17.2% patients have discharged and 81.7% patients remain in hospital in our study, the fatality of COVID-19 infection in Beijing was 0.9%.
Interpretation: On the basis of this study, we provided the ratio of the COVID-19 infection on the severe cases to the mild, asymptomatic and non-pneumonia cases in Beijing. Population was generally susceptible, and with a relatively low fatality rate. The measures to prevent transmission was very successful at early stage, the next steps on the COVID-19 infection should be focused on early isolation of patients and quarantine for close contacts in families and communities in Beijing.
Funding: Beijing Municipal Science and Technology Commission and Ministry of Science and Technology.
Keywords: 2019-nCoV; Beijing; COVID-19; Characteristics.
Copyright © 2020 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest All authors declare no competing interests.
Figures




Comment in
-
Regional air pollution persistence links to COVID-19 infection zoning.J Infect. 2020 Aug;81(2):318-356. doi: 10.1016/j.jinf.2020.03.045. Epub 2020 Apr 10. J Infect. 2020. PMID: 32283151 Free PMC article. No abstract available.
-
Airborne precautions recommended in Wuhan, China for bedside fiberoptic bronchoscopy examination of patients with COVID-19.J Infect. 2020 Jul;81(1):e75-e77. doi: 10.1016/j.jinf.2020.03.055. Epub 2020 Apr 10. J Infect. 2020. PMID: 32283160 Free PMC article. No abstract available.
-
Clinical and laboratory-derived parameters of 119 hospitalized patients with coronavirus disease 2019 in Xiangyang, Hubei Province, China.J Infect. 2020 Jul;81(1):147-178. doi: 10.1016/j.jinf.2020.03.038. Epub 2020 Apr 10. J Infect. 2020. PMID: 32283164 Free PMC article. No abstract available.
-
Characterizing COVID-19 severity, epidemiology and SARS-CoV-2 genotypes in a regional business hub of China.J Infect. 2021 Feb;82(2):282-327. doi: 10.1016/j.jinf.2020.08.031. Epub 2020 Aug 25. J Infect. 2021. PMID: 32853601 Free PMC article. No abstract available.
Similar articles
-
Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study.J Med Microbiol. 2020 Aug;69(8):1114-1123. doi: 10.1099/jmm.0.001231. J Med Microbiol. 2020. PMID: 32783802 Free PMC article.
-
Clinical characteristics of older patients infected with COVID-19: A descriptive study.Arch Gerontol Geriatr. 2020 Jul-Aug;89:104058. doi: 10.1016/j.archger.2020.104058. Epub 2020 Apr 10. Arch Gerontol Geriatr. 2020. PMID: 32339960 Free PMC article.
-
Investigation of a COVID-19 outbreak in Germany resulting from a single travel-associated primary case: a case series.Lancet Infect Dis. 2020 Aug;20(8):920-928. doi: 10.1016/S1473-3099(20)30314-5. Epub 2020 May 15. Lancet Infect Dis. 2020. PMID: 32422201 Free PMC article.
-
Maternal and infant outcomes of full-term pregnancy combined with COVID-2019 in Wuhan, China: retrospective case series.Arch Gynecol Obstet. 2020 Sep;302(3):545-551. doi: 10.1007/s00404-020-05573-8. Epub 2020 Jul 21. Arch Gynecol Obstet. 2020. PMID: 32696241 Free PMC article. Review.
-
Coronavirus Disease 2019 (COVID-19) and pregnancy: what obstetricians need to know.Am J Obstet Gynecol. 2020 May;222(5):415-426. doi: 10.1016/j.ajog.2020.02.017. Epub 2020 Feb 24. Am J Obstet Gynecol. 2020. PMID: 32105680 Free PMC article. Review.
Cited by
-
Exploring the Demographics and Clinical Characteristics Related to the Expression of Angiotensin-Converting Enzyme 2, a Receptor of SARS-CoV-2.Front Med (Lausanne). 2020 Aug 19;7:530. doi: 10.3389/fmed.2020.00530. eCollection 2020. Front Med (Lausanne). 2020. PMID: 32974373 Free PMC article.
-
Why lockdown? Why national unity? Why global solidarity? Simplified arithmetic tools for decision-makers, health professionals, journalists and the general public to explore containment options for the 2019 novel coronavirus.Infect Dis Model. 2020 Jul 3;5:442-458. doi: 10.1016/j.idm.2020.06.006. eCollection 2020. Infect Dis Model. 2020. PMID: 32691016 Free PMC article.
-
The Impact of Angiotensin-Converting Enzyme-2/Angiotensin 1-7 Axis in Establishing Severe COVID-19 Consequences.Pharmaceutics. 2022 Sep 8;14(9):1906. doi: 10.3390/pharmaceutics14091906. Pharmaceutics. 2022. PMID: 36145655 Free PMC article. Review.
-
A Pediatric Infectious Diseases Perspective of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Novel Coronavirus Disease 2019 (COVID-19) in Children.J Pediatric Infect Dis Soc. 2020 Nov 10;9(5):596-608. doi: 10.1093/jpids/piaa099. J Pediatric Infect Dis Soc. 2020. PMID: 32840614 Free PMC article. Review.
-
The Course of Mild and Moderate COVID-19 Infections-The Unexpected Long-Lasting Challenge.Open Forum Infect Dis. 2020 Jul 23;7(9):ofaa286. doi: 10.1093/ofid/ofaa286. eCollection 2020 Sep. Open Forum Infect Dis. 2020. PMID: 32929402 Free PMC article.
References
-
- WHO. World experts and funders set priorities for COVID-19 research. Feb 12, 2020. https://www.who.int/news-room/detail/12-02-2020-world-experts-and-funder...(accessed Feb 13, 2020)
-
- China National Health Commission. February 10, 2020, update on the novel coronavirus pneumonia outbreak). Beijing: national health commission of the People's Republic of China, 2020. http://www.nhc.gov.cn/xcs/yqtb/202002/4a611bc7fa20411f8ba1c8084426c0d4.s...(accessed Feb 10, 2020)
-
- Beijing Health Commission . Beijing Health Commission; Beijing: 2020. Update on the novel coronavirus pneumonia outbreak.http://wjw.beijing.gov.cn/xwzx_20031/wnxw/202002/t20200211_1628034.html February 10, 2020. (accessed Feb 5, 2020)
-
- Munster V.J., Koopmans M., van Doremalen N. A novel coronavirus emerging in China-key questions for impact assessment. N Engl J Med. 2020 Jan 24 (Epub ahead of print) - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous